Sugi Predict

Sugi Predict / Compounds / SCHEMBL1221986

SCHEMBL1221986

SCHEMBL1221986

O=C(O)C1CCN(C(=O)CCc2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 1.00
▸ L3MBTL1 Q9Y468 2/20 0.72
▸ NPC1 O15118 2/20 0.69
▸ TDP1 Q9NUW8 1/20 0.69
▸ FKBP1A P62942 1/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ NAAA Q02083 1/20 0.57
▸ GRIN2B Q13224 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ ME2 P23368 1/20 0.56
▸ ME1 P48163 1/20 0.56
▸ ME3 Q16798 1/20 0.56
▸ KMT2A Q03164 2/20 0.55
▸ GFER P55789 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ CHRM3 P20309 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306852 0.91 POLB (0.83) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL5369479 0.88 POLB (0.78) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL6289171 0.87 POLB (0.77) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL16846602 0.87 POLB (0.76) POLBL3MBTL1NPC1TDP1NAAA
SCHEMBL4704100 0.86 POLB (0.75) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL7131839 0.85 NPC1 (0.86) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL4704483 0.84 POLB (0.73) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL14028152 0.84 POLB (0.73) POLBL3MBTL1NPC1TDP1FKBP1A
SCHEMBL7309037 0.84 L3MBTL1 (1.00) POLBL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL1222959 0.83 POLB (0.71) POLBL3MBTL1NPC1TDP1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US claimed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US claimed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 — — WO claimed
US-8877968-B2 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics GALDERMA RESEARCH & DEVELOPMENT (FR) 2014-11-04 — — US disclosed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 — — US disclosed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 — — US disclosed
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 — — US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US disclosed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 — — WO disclosed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 — — WO disclosed
WO-2005023794-A2 COMPOUND LIBRARIES OF 4-CARBOXAMIDOPIPERIDINE DERIVATIVES BIOFOCUS PLC (GB) 2005-03-17 — — WO disclosed
EP-0520336-A2 Aldehyde derivatives and their use as calpain inhibitors FUJIREBIO Inc. (JP) 1992-12-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 POLB 1958/4885L3MBTL1 4330/4885NPC1 206/4885
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 POLB 1958/4885L3MBTL1 4330/4885NPC1 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.